Reports: Administration budget seeking $4.7 billion for the Food and Drug Administration
WASHINGTON — The administration is seeking $4.7 billion for the Food and Drug Administration, representing a 6.8% increase, according to a report published Tuesday by the Washington Post.
According to the report, the budget includes $25 million to register and inspect large-scale compounding pharmacies.
“This is really quite a positive outcome for the FDA in this tight budget environment,” said FDA Commissioner Margaret A. Hamburg the Post reported. “I consider the additional funding for the agency to be a tribute to the important work the FDA performs on behalf of the American people, the hard work and dedication of FDA employees, and our ability to meaningfully demonstrate the value of our work to stakeholders.”
Low flu incidence a drag on February sales at Rite Aid, but comparable sales still up 1.5%
CAMP HILL, Pa. — Rite Aid on Thursday posted a 1.5% increase in same-store sales for the five weeks ended March 1. February front-end same-store sales decreased 1.8%, of which 0.5% was attributable to a decrease in sales of flu-related over-the-counter products. Pharmacy same-store sales, which included an approximate 138 basis points negative impact from new generic introductions, increased 3.1%.
For the 13-week quarter, Rite Aid recorded a same-store sales increase of 2.1%. Front-end same-store sales decreased 0.7% while pharmacy same-store sales increased 3.5%. Prescription count at comparable stores decreased 1.8% over the prior-year period.
For the five-week period prescription count at comparable stores decreased 1.4% over the prior-year period, of which 1.3% was attributable to a decrease in flu-related prescriptions.
Total drug store sales for the five-week period increased 2.4% to $2.5 billion. Prescription sales accounted for 69.1% of drug store sales, and third party prescription sales represented 97.3% of pharmacy sales.
Total drug store sales for the 13 weeks ended March 1, 2014 increased 2.2% with sales of $6.6 billion. Prescription sales represented 67.5% of total drug store sales, and third party prescription sales represented 97.1% of pharmacy sales.
Year-to-date Rite Aid has generated $25.4 billion in sales, representing a 0.5% increase.
Grand View Research: Global mHealth market to exceed $20 billion by 2020
SAN FRANCISCO — Grand View Research projects that the global mHealth market will reach well in excess of $20 billion from a base of $2 billion in 2012, as part of a recent market research study. Between 2014 and 2020, the firm estimates a CAGR of 47.6%.
In 2012, monitoring services represented the largest segment, accounting for about 63% of the overall market share. Monitoring services include independent aging solutions, chronic disease management and post acute care services, as well as devices such as body trackers that are employed to monitor vital signs.
In addition to monitoring services, key mHealth services analyzed and reported in the study include diagnostic services and healthcare systems strengthening. Other services primarily comprise wellness and prevention, and are focused on elderly care, drug abuse prevention, healthy living, smoking de-addiction and child care.
These mHealth services will be most prevalent in large urban centers. Growing urbanization and purchasing power has resulted in proliferation of smartphones and related devices, along with 3G and 4G networks, which is expected to be a significant driving force for the industry on a global scale, Grand View Research reported. 3G and 4G LTE networks enable services such as high-speed data transfer and video calling, which helps in rapid delivery of telemedicine services.
And rising incidences of chronic diseases such as cancer, heart ailments and diabetes is also a key contributor to growing demand, the firm added. Changing lifestyle and increasing aging population has resulted in growing prevalence of diseases, and mobile applications help patients control and manage them efficiently.
However, security concerns and the need to maintain a secure infrastructure to ensure data safety and privacy may negatively impact the market over the next six years, Grand View Research cautioned.